NewcelX Ltd. (NCEL)Healthcare | Biotechnology | Zurich, Switzerland | NasdaqCM
3.15 USD
+0.32
(11.307%)
⇧
(April 21, 2026, 12:11 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 11:20 p.m. EDT
High volatility following reported strategic partnerships and a successful cash raise creates allure, but the lack of a clear upside IV as fundamentals remain deteriorated (negative equity, losses, and low current ratio) and short-term outlook is slightly bearish means the risk/reward heavily favors patience over action. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.089306 |
| AutoETS | 0.091502 |
| AutoARIMA | 0.091506 |
| AutoTheta | 0.108762 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 23% |
| H-stat | 15.36 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.007 |
| Excess Kurtosis | 0.98 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 15,905,251 |
| Beta | 0.57 |
| Previous Name | Kadimastem Ltd |
| Website | https://newcelx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8020979 |
| Address1 | The Circle 6 |
| All Time High | 2,940.0 |
| All Time Low | 1.83 |
| Ask | 2.84 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 24,670 |
| Average Daily Volume3 Month | 32,886 |
| Average Volume | 32,886 |
| Average Volume10Days | 24,670 |
| Beta | 0.574 |
| Bid | 2.58 |
| Bid Size | 1 |
| Book Value | -11.276 |
| City | Zurich |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | Switzerland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.15 |
| Current Ratio | 0.023 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.15 |
| Day Low | 2.8801 |
| Display Name | NewcelX |
| Ebitda | -9,115,000 |
| Ebitda Margins | 0.0 |
| Eps Trailing Twelve Months | -6.88 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 41 44 512 21 51 |
| Fifty Day Average | 2.59 |
| Fifty Day Average Change | 0.5600002 |
| Fifty Day Average Change Percent | 0.2162163 |
| Fifty Two Week Change Percent | -80.20979 |
| Fifty Two Week High | 30.8 |
| Fifty Two Week High Change | -27.65 |
| Fifty Two Week High Change Percent | -0.8977273 |
| Fifty Two Week Low | 1.83 |
| Fifty Two Week Low Change | 1.32 |
| Fifty Two Week Low Change Percent | 0.7213115 |
| Fifty Two Week Range | 1.83 - 30.8 |
| Financial Currency | ILS |
| First Trade Date Milliseconds | 1,611,930,600,000 |
| Float Shares | 2,012,216 |
| Free Cashflow | 37,313,876 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 11 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.71308 |
| Held Percent Institutions | 0.04157 |
| Implied Shares Outstanding | 5,049,286 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Language | en-US |
| Last Fiscal Year End | 1,735,603,200 |
| Last Split Date | 1,761,868,800 |
| Last Split Factor | 1:10 |
| Long Business Summary | NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland. |
| Long Name | NewcelX Ltd. |
| Market | us_market |
| Market Cap | 15,905,251 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_224505747 |
| Most Recent Quarter | 1,751,241,600 |
| Name Change Date | 2,026-04-20 |
| Next Fiscal Year End | 1,767,139,200 |
| Non Diluted Market Cap | 14,289,476 |
| Open | 2.97 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 41 44 512 21 50 |
| Prev Name | Kadimastem Ltd |
| Previous Close | 2.83 |
| Price Hint | 4 |
| Price To Book | -0.2793544 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.023 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.32000017 |
| Regular Market Change Percent | 11.307426 |
| Regular Market Day High | 3.15 |
| Regular Market Day Low | 2.8801 |
| Regular Market Day Range | 2.8801 - 3.15 |
| Regular Market Open | 2.97 |
| Regular Market Previous Close | 2.83 |
| Regular Market Price | 3.15 |
| Regular Market Time | 1,776,787,887 |
| Regular Market Volume | 123,921 |
| Return On Assets | -1.55185 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 5,049,285 |
| Shares Percent Shares Out | 0.0076 |
| Shares Short | 36,007 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 96,641 |
| Short Name | NewcelX Ltd. |
| Short Ratio | 1.61 |
| Source Interval | 15 |
| Symbol | NCEL |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -6.88 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.194275 |
| Two Hundred Day Average Change | -7.044275 |
| Two Hundred Day Average Change Percent | -0.691003 |
| Type Disp | Equity |
| Volume | 123,921 |
| Website | https://newcelx.com |
| Zip | 8,058 |